|
GENTAM
®
Gentamicin Sulphate
80/20 Injection
|
|

|
|
|
COMPOSITION
GENTAM injection
is a sterile aqueous solution for parenteral administration.
Each ml of (GENTAM 80) contains Gentamicin Sulphate BP equivalent
to 40 mg Gentamicin base.
Each ml of (GENTAM 20) contains Gentamicin Sulphate BP equivalent
to 10 mg Gentamicin base.
|
|
PROPERTIES
Gentamicin Sulphate
is a bactericidal aminoglycoside antibiotic active against a wide
variety of pathogenic gram- negative and some gram-positive bacteria.
Susceptible organisms include: Pseudomonas aeruginosa, proteus species
(indole-positive and indole-negative), Escherichia Coli, Klebsiella,
Enterobacter, Serratia species, Neisseria gonorrhea and Staphylococcus
species (penicillinase producing and non penicillinase producing).
|
|
INDICATIONS
GENTAM injection
is indicated in urinary-tract infections, chest infections, bacteremia,
septicaemia, infections following burns, infected traumatic or surgical
wounds and other systemic infections due to sensitive organisms.
GENTAM is usually given intramuscularly, but may be given intravenously
if necessary, e.g. in patients with shock, in severe burns or reduced
muscle mass. The same dosages are recommended for intramuscular
and intravenous use. Direct injection into a vein should be over
a period of two to three minutes. Administration by infusion should
be completed over a period not less than 20 minutes and in no greater
volume of fluid than 100ml. GENTAM injection should not be mixed
in same syringe with any other drug prior to administration.
|
|
DOSAGE
AND ADMINISTRATION
ADULTS :
1. Serious infections : 5 mg/kg daily in equally divided doses every
6-8 hours.
2. Other systemic infections : 80 mg every 8 hours for 7-10 days.
3. Urinary tract infections : As for systemic infections or if renal
function is not impaired,160 mg once daily.
CHILDREN: (1-12 Years) 2 mg/kg every 8 hours.
INFANTS: (Birth-12 months) 3 mg/kg every 12 hours.
GENTAM is excreted by simple glomerular filtration and therefore
is given in reduced dosage in the case of renal impairment.
The following table may be used when treating adults:
BLOOD
UREA
(mg/100ml)
|
(m
mol / I)
|
Creatinine
Clearance(GFR)
(ml / min)
|
Dose
& Frequencyof Administration
|
<40
|
6-7
|
>70
|
*80
mg every 8 hours
|
40-100
|
6-17
|
30-70
|
*80
mg every 12 hours
|
100-200
|
17-34
|
10-30
|
*80
mg daily
|
>200
|
>34
|
5-10
|
*80
mg every 48 hours
|
Twice-Weekly
intermittent
|
Haemodialysis
|
<5
|
*80
mg after dialysis
|
* 60 mg if body weight
is less than 60 kg.
Frequency of dosage in hours may also be approximated as serum creatinine
(mg/100 ml) x 8 (eight) or in SI units: as serum levels must be
measured . Peak levels of Gentamicin occur approximately one hour
after intramuscular injection and 15 minutes after bolus intravenous
injection. The possibility of ototoxicity should be considered for
peak levels above 10 mcg/ml.
|
|
CONTRAINDICATIONS
Hypersensitivity to Gentamicin or to other
aminoglycosides. Because of ototoxicity and nephrotoxic hazards
of extended administration, Gentamicin, like other aminoglycoside
antibiotics is generally not indicated in long term therapy.
|
|
|
PRECAUTIONS
Closely observe all patients treated with
aminoglycosides. GENTAM should not be used during pregnancy, except
in life threatening situations. Hearing loss (vestibular damage)
has seldom been manifested following the use of Gentamicin usually
in the presence of impaired renal function following higher dosage
or more prolonged administration than that recommended. In some
patients with impaired renal function there has been a transient
rise in blood urea-nitrogen, which usually returns to normal during
or following cessation of therapy. Concurrent administration of
Gentamicin and potentially ototoxic or nephrotoxic substances should
be avoided. Neuromuscular blockade and respiratory paralysis have
been reported from administration of aminoglycosides to patients
who have received curare-type muscle relaxants during anaesthesia.
|
|
SIDE
EFFECTS
Rash, itching, urticaria and pain at injection
site. Renal, hepatic, haematologic, auditory and C.N.S. side effects
have been reported and are related to dose and duration of treatment.
|
|
OVERDOSAGE
In the event of overdosage or toxic reaction,
peritoneal dialysis or haemodialysis will aid in removal from the
blood. Haemodialysis is preferable because it is more efficient
in reducing serum levels.
|
|
PRESENTATIONS
GENTAM 80(40 mg/ml):
available as 2 ml (80 mg) ampoules, packs of 5 ampoules. GENTAM
20(10 mg/ml): available as 2 ml (20 mg) ampoules, packs of 5 ampoules.
|